The Consequences Of Coronavirus Will Be Treated With A Drug From The Kirov Pharmaceutical Company

The Consequences Of Coronavirus Will Be Treated With A Drug From The Kirov Pharmaceutical Company
The Consequences Of Coronavirus Will Be Treated With A Drug From The Kirov Pharmaceutical Company

Video: The Consequences Of Coronavirus Will Be Treated With A Drug From The Kirov Pharmaceutical Company

Отличия серверных жестких дисков от десктопных
Video: Coronavirus medication: What works, what doesn't | COVID-19 Special 2023, January
Anonim

The first 10 thousand kilograms of the drug have already been supplied from the Vostok plant

Image
Image

The first batch of the drug "Polyphepan", which is produced at LLC "Vostok" in the village of Vostochny Omutininsky district, has already been sent to one of the largest pharmaceutical companies in Russia GK "PROTEK" Group of companies "Protek" occupies a leading position in all major segments of the pharmaceutical industry: funds, distribution of pharmaceuticals and health and beauty products, and retail sales. And Vostok LLC became a partner of one of the largest players in the pharmaceutical market JSC Protek in our region. On March 2, Vostok delivered the first 10 thousand kilograms of Polyphepan to the Protek Group.

Recall that the production of polyphepan at the site of the Vostok LLC biotechnological cluster in the Omutininsky district started in May 2017. The head of the Kirov region Igor Vasiliev took part in the launch of the new production site, emphasizing the importance of interaction between the real sector of the economy and the authorities.

Previously, the Vostok plant acquired the exclusive rights to the production of the pharmaceutical substance Polyphepan and the medicines Polyphepan in the form of powder, granules and tablets in 2016 from the Saintek company (St. Petersburg). In the village of Vostochny, a site was built for the production of Polyphepan, investments in which to date have exceeded 150 million rubles.

Polyphepan is a natural sorbent based on hydrolytic lignin. The drug helps with intoxication, gastric disorders and is several times more effective than activated carbon. One of the main properties of Polyphepan is the elimination of mycotoxins from the body, which is especially in demand in the rehabilitation of patients after covid and the use of antibiotics, - emphasized the representatives of Vostok LLC.

Hydrolysis lignin, which is the basis of the natural sorbent Polyphepan, is obtained in the process of hydrolysis from natural raw materials at the Kirov Biochemical Plant. At the production site in the village of Vostochny, a substance is produced from lignin and processed into a ready-to-use drug.

Investments in the construction of a site for the new production amounted to more than 150 million rubles for all this time, - says Dmitry Panteleev, General Director of Vostok LLC. - Our drug is in demand on the market and is already expected.

The Minister of Industrial Policy of the Kirov Region, Andrey Pereskokov, noted the importance of the release of the drug produced in the region on the Russian pharmaceutical market. He especially noted that the government and relevant ministries will continue to work together productively with regional enterprises. LLC "Vostok" is a participant in a federal project to create a comprehensive tool for emergency prevention and treatment of anthrax in humans. Interdepartmental acceptance of the preliminary design of the complex tool has already taken place. The co-executors, along with OOO Vostok, were the Kirov Research Institute of Hematology and Blood Transfusion and branch 48 of the Central Research Institute of the Ministry of Defense of the Russian Federation.

Popular by topic